Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Stimulants improve theory of mind in children with attention deficit/hyperactivity disorder.

Maoz H, Tsviban L, Gvirts HZ, Shamay-Tsoory SG, Levkovitz Y, Watemberg N, Bloch Y.

J Psychopharmacol. 2014 Mar;28(3):212-9. doi: 10.1177/0269881113492030. Epub 2013 Jun 12.

PMID:
23761389
[PubMed - in process]
2.

Motivational incentives and methylphenidate enhance electrophysiological correlates of error monitoring in children with attention deficit/hyperactivity disorder.

Groom MJ, Liddle EB, Scerif G, Liddle PF, Batty MJ, Liotti M, Hollis CP.

J Child Psychol Psychiatry. 2013 Aug;54(8):836-45. doi: 10.1111/jcpp.12069. Epub 2013 May 13.

PMID:
23662815
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Subtle deficits of cognitive theory of mind in unaffected first-degree relatives of schizophrenia patients.

Montag C, Neuhaus K, Lehmann A, Krüger K, Dziobek I, Heekeren HR, Heinz A, Gallinat J.

Eur Arch Psychiatry Clin Neurosci. 2012 Apr;262(3):217-26. doi: 10.1007/s00406-011-0250-2. Epub 2011 Sep 4.

PMID:
21892777
[PubMed - indexed for MEDLINE]
4.

Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.

Klassen AF, Miller A, Fine S.

Pediatrics. 2004 Nov;114(5):e541-7.

PMID:
15520087
[PubMed - indexed for MEDLINE]
5.

Stimulant drug response in the predominantly inattentive and combined subtypes of attention-deficit/hyperactivity disorder.

Solanto M, Newcorn J, Vail L, Gilbert S, Ivanov I, Lara R.

J Child Adolesc Psychopharmacol. 2009 Dec;19(6):663-71. doi: 10.1089/cap.2009.0033.

PMID:
20035584
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorder.

Tucha O, Prell S, Mecklinger L, Bormann-Kischkel C, Kübber S, Linder M, Walitza S, Lange KW.

Psychopharmacology (Berl). 2006 Apr;185(3):315-26. Epub 2006 Mar 7.

PMID:
16521033
[PubMed - indexed for MEDLINE]
7.

Social cognition in attention-deficit hyperactivity disorder (ADHD).

Uekermann J, Kraemer M, Abdel-Hamid M, Schimmelmann BG, Hebebrand J, Daum I, Wiltfang J, Kis B.

Neurosci Biobehav Rev. 2010 Apr;34(5):734-43. doi: 10.1016/j.neubiorev.2009.10.009. Epub 2009 Oct 24. Review.

PMID:
19857516
[PubMed - indexed for MEDLINE]
8.

Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder.

Wigal SB, Wigal T, Schuck S, Brams M, Williamson D, Armstrong RB, Starr HL.

J Child Adolesc Psychopharmacol. 2011 Apr;21(2):121-31. doi: 10.1089/cap.2010.0047. Epub 2011 Apr 13.

PMID:
21488750
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.

Wu EQ, Birnbaum HG, Zhang HF, Ivanova JI, Yang E, Mallet D.

J Manag Care Pharm. 2007 Sep;13(7):561-9.

PMID:
17874862
[PubMed - indexed for MEDLINE]
Free Article
10.

Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.

Huang YS, Guilleminault C, Li HY, Yang CM, Wu YY, Chen NH.

Sleep Med. 2007 Jan;8(1):18-30. Epub 2006 Dec 6.

PMID:
17157069
[PubMed - indexed for MEDLINE]
11.

The effects of methylphenidate on cognitive function in children with attention-deficit/hyperactivity disorder.

Kubas HA, Backenson EM, Wilcox G, Piercy JC, Hale JB.

Postgrad Med. 2012 Sep;124(5):33-48. doi: 10.3810/pgm.2012.09.2592.

PMID:
23095424
[PubMed - indexed for MEDLINE]
12.

Theory of mind deficits in patients with esophageal cancer combined with depression.

Cao Y, Zhao QD, Hu LJ, Sun ZQ, Sun SP, Yun WW, Yuan YG.

World J Gastroenterol. 2013 May 21;19(19):2969-73. doi: 10.3748/wjg.v19.i19.2969.

PMID:
23704831
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

[Comorbidities and functional impairments in children with attention deficit hyperactivity disorder].

Xiao ZH, Wang QH, Luo TT, Zhong L.

Zhongguo Dang Dai Er Ke Za Zhi. 2013 Sep;15(9):728-32. Chinese.

PMID:
24034913
[PubMed - indexed for MEDLINE]
Free Article
14.

Age-dependent neuropsychological deficits and effects of methylphenidate in children with attention-deficit/hyperactivity disorder: a comparison of pre- and grade-school children.

Hanisch C, Konrad K, Günther T, Herpertz-Dahlmann B.

J Neural Transm. 2004 Jul;111(7):865-81. Epub 2004 Feb 4.

PMID:
15206003
[PubMed - indexed for MEDLINE]
15.

The influence of methylphenidate on the power spectrum of ADHD children - an MEG study.

Wienbruch C, Paul I, Bauer S, Kivelitz H.

BMC Psychiatry. 2005 Jul 26;5:29.

PMID:
16042816
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits.

Leitner Y, Doniger GM, Barak R, Simon ES, Hausdorff JM.

J Child Neurol. 2007 Mar;22(3):264-76.

PMID:
17621495
[PubMed - indexed for MEDLINE]
17.

Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders.

Riggs PD, Winhusen T, Davies RD, Leimberger JD, Mikulich-Gilbertson S, Klein C, Macdonald M, Lohman M, Bailey GL, Haynes L, Jaffee WB, Haminton N, Hodgkins C, Whitmore E, Trello-Rishel K, Tamm L, Acosta MC, Royer-Malvestuto C, Subramaniam G, Fishman M, Holmes BW, Kaye ME, Vargo MA, Woody GE, Nunes EV, Liu D.

J Am Acad Child Adolesc Psychiatry. 2011 Sep;50(9):903-14. doi: 10.1016/j.jaac.2011.06.010. Epub 2011 Aug 4.

PMID:
21871372
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.

Soutullo C, Banaschewski T, Lecendreux M, Johnson M, Zuddas A, Anderson C, Civil R, Higgins N, Bloomfield R, Squires LA, Coghill DR.

CNS Drugs. 2013 Sep;27(9):743-51. doi: 10.1007/s40263-013-0086-6.

PMID:
23801529
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.

Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH.

Pediatrics. 2003 Nov;112(5):e404.

PMID:
14595084
[PubMed - indexed for MEDLINE]
20.

Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD.

Flapper BC, Schoemaker MM.

Dev Med Child Neurol. 2008 Apr;50(4):294-9. doi: 10.1111/j.1469-8749.2008.02039.x.

PMID:
18352997
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk